• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者的健康相关生活质量:一项系统综述。

Health-related quality of life in systemic sclerosis: a systematic review.

作者信息

Hudson Marie, Thombs Brett D, Steele Russell, Panopalis Pantelis, Newton Evan, Baron Murray

机构信息

SMBD-Jewish General Hospital and McGill University, Montreal, Quebec, Canada.

出版信息

Arthritis Rheum. 2009 Aug 15;61(8):1112-20. doi: 10.1002/art.24676.

DOI:10.1002/art.24676
PMID:19644906
Abstract

OBJECTIVE

A number of studies (all n <200) have assessed health-related quality of life (HRQOL) in patients with systemic sclerosis (SSc), but no systematic review of the effect of SSc on HRQOL has been done. The objective of this study was to systematically review the literature on HRQOL in SSc measured using the Medical Outcomes Trust Short Form 36 (SF-36).

METHODS

A comprehensive search was conducted in August 2007 using Medline, CINAHL, and EMBase to identify original research studies reporting SF-36 scores of SSc patients. Selected studies were reviewed and characteristics of the study samples and SF-36 data were extracted. Bayesian meta-analysis and meta-regression were performed to obtain pooled estimates of SF-36 physical component summary (PCS) and mental component summary (MCS) scores for all patients as well as by limited and diffuse disease status.

RESULTS

Twelve data sets with a total of 1,127 SSc patients were included in the systematic review. HRQOL was impaired in patients with SSc, with pooled SF-36 PCS scores being more than 1 SD below the general population (38.3; 95% credible interval [95% CI] 35.2, 41.5) and pooled SF-36 MCS scores being approximately 0.5 SDs below the general population (46.6; 95% CI 44.2, 49.1). SF-36 PCS scores were 3.5 points (95% CI -1.0, 8.0) lower in patients with diffuse compared with limited disease.

CONCLUSION

This study provides robust evidence of the presence and magnitude of impairment in HRQOL in patients with SSc. Although the impairment appears greater in physical health, mental health impairment is also reported.

摘要

目的

多项研究(样本量均n<200)评估了系统性硬化症(SSc)患者的健康相关生活质量(HRQOL),但尚未对SSc对HRQOL的影响进行系统评价。本研究的目的是系统评价使用医学结局信托简短健康调查36项问卷(SF-36)测量的SSc患者HRQOL的相关文献。

方法

2007年8月利用医学数据库(Medline)、护理学与健康领域数据库(CINAHL)和荷兰医学文摘数据库(EMBase)进行全面检索,以识别报告SSc患者SF-36评分的原始研究。对入选研究进行综述,并提取研究样本特征和SF-36数据。进行贝叶斯荟萃分析和荟萃回归,以获得所有患者以及局限性和弥漫性疾病状态下SF-36身体成分汇总(PCS)和精神成分汇总(MCS)评分的合并估计值。

结果

系统评价纳入了12个数据集,共1127例SSc患者。SSc患者的HRQOL受损,SF-36 PCS合并评分比一般人群低1个标准差以上(38.3;95%可信区间[95%CI]35.2,41.5),SF-36 MCS合并评分比一般人群低约0.5个标准差(46.6;95%CI 44.2,49.1)。与局限性疾病患者相比,弥漫性疾病患者的SF-36 PCS评分低3.5分(95%CI -1.0,8.0)。

结论

本研究提供了有力证据证明SSc患者HRQOL受损的存在及其程度。虽然身体健康方面的损害似乎更大,但也有心理健康受损的报告。

相似文献

1
Health-related quality of life in systemic sclerosis: a systematic review.系统性硬化症患者的健康相关生活质量:一项系统综述。
Arthritis Rheum. 2009 Aug 15;61(8):1112-20. doi: 10.1002/art.24676.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
5
Stem cell transplantation for systemic sclerosis.系统性硬皮病的干细胞移植。
Cochrane Database Syst Rev. 2022 Jul 29;7(7):CD011819. doi: 10.1002/14651858.CD011819.pub2.
6
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.用于预防或治疗早期乳腺癌中芳香化酶抑制剂引起的肌肉骨骼症状的系统治疗。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD013167. doi: 10.1002/14651858.CD013167.pub2.
7
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
8
Patient education in the management of coronary heart disease.冠心病管理中的患者教育
Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3.
9
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
10
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.

引用本文的文献

1
Psychosomatic profile in patients with systemic sclerosis: results from an observational study.系统性硬化症患者的心身状况:一项观察性研究的结果
Front Med (Lausanne). 2025 Jul 8;12:1631450. doi: 10.3389/fmed.2025.1631450. eCollection 2025.
2
The assessment of psychological well-being in systemic sclerosis: a clinimetric validation.系统性硬化症中心理幸福感的评估:临床计量学验证
BMC Psychol. 2025 May 12;13(1):498. doi: 10.1186/s40359-025-02820-y.
3
The effect of self-management program performed via telerehabilitation on occupational performance and satisfaction of individuals with systemic sclerosis.
通过远程康复实施的自我管理计划对系统性硬化症患者职业表现和满意度的影响。
Br J Occup Ther. 2025 Mar;88(3):185-192. doi: 10.1177/03080226241283288. Epub 2024 Sep 20.
4
Occupational history of psychosocial work environment exposures and risk of autoimmune rheumatic diseases - a Danish register-based cohort study.心理社会工作环境暴露的职业史与自身免疫性风湿病风险——一项基于丹麦登记处的队列研究。
Scand J Work Environ Health. 2025 May;51(3):226-236. doi: 10.5271/sjweh.4220. Epub 2025 Mar 17.
5
A phase 2 randomized trial of safety and pharmacokinetics of IgPro20 and IgPro10 in patients with diffuse cutaneous systemic sclerosis.IgPro20和IgPro10在弥漫性皮肤系统性硬化症患者中的安全性和药代动力学的2期随机试验。
Rheumatology (Oxford). 2025 Jun 1;64(6):3657-3666. doi: 10.1093/rheumatology/keaf066.
6
Impact of gastrointestinal symptoms and psychological distress on quality of life in systemic sclerosis: a cross-sectional study.胃肠道症状和心理困扰对系统性硬化症患者生活质量的影响:一项横断面研究。
BMJ Open. 2024 Nov 27;14(11):e089725. doi: 10.1136/bmjopen-2024-089725.
7
Effects of probiotics supplementation in gastrointestinal complications and quality of life of patients with systemic sclerosis: A systematic review.补充益生菌对系统性硬化症患者胃肠道并发症及生活质量的影响:一项系统评价。
Heliyon. 2024 Aug 13;10(16):e36230. doi: 10.1016/j.heliyon.2024.e36230. eCollection 2024 Aug 30.
8
Emotional intelligence: a novel predictor of quality of life in patients with systemic sclerosis.情绪智力:系统性硬化症患者生活质量的新预测因子。
Rheumatol Int. 2024 Oct;44(10):1967-1974. doi: 10.1007/s00296-024-05656-8. Epub 2024 Jul 12.
9
Protocol for the development of a tool to map systemic sclerosis pain sources, patterns, and management experiences: a Scleroderma Patient-centered Intervention Network patient-researcher partnership.用于绘制系统性硬化症疼痛源、模式及管理经验的工具开发方案:硬皮病患者中心干预网络患者 - 研究人员合作项目
BMC Rheumatol. 2024 Jun 21;8(1):28. doi: 10.1186/s41927-024-00398-3.
10
Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis.系统性硬化症患者中土耳其语版硬皮病皮肤患者报告结局的信度和效度
Arch Rheumatol. 2023 Jun 14;39(1):52-59. doi: 10.46497/ArchRheumatol.2023.10183. eCollection 2024 Mar.